AAAAAA

   
Results: 1-8 |
Results: 8
DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M DELFAVERO A CICCARESE G BASURTO C CICCARESE G PALLADINO MA PORROZZI S PICCIAFUOCO M CONTU A OLMEO N PAZZOLA A PILO L TATEO S CHIAPPARINI I MORANA S LUCCHINO S RICCI S ANTONUZZO A ALLEGRINI G GALLI L CONTE PF MASSIDDA B IONTA MT SCANU A MURRU R PICECE V CIRILLO M MAGAROTTO R NUZZO A LAUDADIO L SABLONE MG LOCATELLI MC DANTONA A LUPORINI G SCAGLIOTTI G SELVAGGI G MATTEI A FAVALLI G GAMBINO A FAVA S GRIMI E SCARFONE G BOLIS MC ALESSANDRONI P CATALANO G BONI C MORETTI G CORTESI E MARTELLI O ANTIMI M BELLINI V BUZZI E BRUGIA M GRECCHI M CLERICO M MONTINARI F DONATI D SANSONI E
Citation: F. Roila et al., DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS, Journal of clinical oncology, 16(9), 1998, pp. 2937-2942
ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER
Authors: PARMAR MKB TORRI V BONAVENTURA A BONAZZI C COLOMBO N DELALOYE JF MARSONI S MANGIONI C SANDERCOCK J SESSA C WILLIAMS C TINAZZI A FLANN M GEISER K SCORPIGLIONE N STEWART JF CHAVES J PALMEIRO E CURTAIN A MCCORMACK T GENNATAS C MARRAS F OPPO TG BALESTRINO M MALZONI C MALZONI M BELLI M GEMINIANI ML CRESTANI G MONACO A VAVALA V PIATTO E BARATTINI G FORNARA PG CHETRI MC SANTEUFEMIA G ARTIOLI F CARONE D FANIZZA G TRENTADUE R PRIOLO D SCOLLO P NIGRO SC PETRINA M MASTRANTONIO P SPANNA GD ZAGNI R BELLONI C COLLEONI R REDAELLI L CAVAGNINI A DICOSTANZO G PERRONI D ARIENTI S ORFANOTTI G CANTONI FM SECLI R BIANCHI A MARTINELLO R MOLLICA G MAIZZI D PICCHIARELLI ME FIORINI G BORSANI M COLOMBO E GARSIA S MELGRATI L PAGGI G BRUNENGHI GM CASINI M ISA L ALGERI R PROZIO G BELFIORE G ANGELINI F DAPRILE M MORESCHI M MAURI ML NATALE N SENZANI FM PAVANATO G POGGI G GARUTI G LUERTI M CRUCIANI G PAGANO F BACCOLO M PODDI ER BOCCIOLONE L SABELLI MA MAGGI R RESTELLI C DANTONA A LOCATELLI MC PESSI A RAINA A CHIARI S GABRIELE A PITTELLI MR IACOBELLI P DOGLIOTTI L GORZEGNO G MUSSO P VEGNA G COCO G ALLETTI DG PICCIOTTO F LUCCHESE V EPIS A DIPALUMBO VS DRUDI G RAVAIOLI A ZAMPELLA D MORANDI MG GORGA G ZUCCHELLI C CARIELLO S GALLETTO L SUSSIO M MASSACESI L MASSACESI M CARLI A TUCCI E TAJANI E CORRADO G BUMMA S DURANDO A MASSOBRIO M SBERVEGLIERI M BIASIO M GUERCIO E JURA R DANESE S WIERDIS T FARNELLI C TARANTINO G GRASSI R REPETTI F ROCCHI B GRAMPA M ERCOLI A GRISO C SIGNORI E ZANINI L PRESTI M KLIMEK M URBANSKI K BISWAS A VIEGAS O KOCHLI O DREHER E FEY M BECK G LUDIN J BONNEFOI H KRAUER F BAUER J DELMORE G FURRER C LORENZ U THURLIMANN B LORENZ U BRONZ L SANNA P WYSS D GOLDHIRSCH A GYR T LEIDI L PASTORELLI G PAGANI O REY P HAILER U BENZ J KAYE SB REED NS SYMONDS RP ATKINSON RJ AXFORD AT RUSTIN G SECKL MJ GREEN JA SCOTT IV GUTHRIE D HARPER PG CALMAN F DOBBS HJ WEIR P CASSONI A LEDERMAN JA SOUHAMI RL BOZZINO J ADAB F REDMAN CWE SCOBLE JE PATERSON M DANIEL F COWLEY N WILLIAMS CJ SPOONER D HONG A MCILLMURRAY M HENDYIBBS P HALL V IVESON TJ WHITEHOUSE JMA GARRY R LAMONT A ROBINSON A TRASK CW CLUBB AW MURRELL D NEWMAN G WILKINS M GOLDTHORP WO ROBERTS JK RADSTONE DJ WHIPP MJ LEDERMANN JA PATER J BUYSE M OMURA G
Citation: Mkb. Parmar et al., ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER, Lancet, 352(9140), 1998, pp. 1571-1576
CISPLATIN-ASSOCIATED ANEMIA IN PATIENTS WITH SOLID TUMORS - A RETROSPECTIVE EVALUATION AND CONSIDERATIONS RELATIVE TO ERYTHROPOIETIN ADMINISTRATION
Authors: LOCATELLI MC TEDESCHI L CLERICI M ROMANELLI A DANTONA A LABIANCA R LUPORINI G
Citation: Mc. Locatelli et al., CISPLATIN-ASSOCIATED ANEMIA IN PATIENTS WITH SOLID TUMORS - A RETROSPECTIVE EVALUATION AND CONSIDERATIONS RELATIVE TO ERYTHROPOIETIN ADMINISTRATION, Supportive care in cancer, 4(3), 1996, pp. 218-219
SALVAGE CHEMOTHERAPY WITH PACLITAXEL IN PLATINUM-RESISTANT ADVANCED OVARIAN-CANCER PATIENTS
Authors: BRUZZONE M CATSAFADOS E MIGLIETTA L AMOROSO D PEDULLA F GIANNESSI PG LOCATELLI MC DANTONA A FOGLIA G MAMMOLITI S TURNO F GENTILE A NICOSIA F LUPORINI G RAGNI N BOCCARDO F
Citation: M. Bruzzone et al., SALVAGE CHEMOTHERAPY WITH PACLITAXEL IN PLATINUM-RESISTANT ADVANCED OVARIAN-CANCER PATIENTS, Oncology, 53(5), 1996, pp. 349-353
EVALUATION OF INCIDENCE OF CISPLATIN (CDDP) - ANEMIA DEVELOPED IN 3 SUBSETS OF NEOPLASTIC PATIENTS (PTS)
Authors: TEDESCHI L LOCATELLI C DANTONA A CLERICI M ROMANELLI A LUPORINI G
Citation: L. Tedeschi et al., EVALUATION OF INCIDENCE OF CISPLATIN (CDDP) - ANEMIA DEVELOPED IN 3 SUBSETS OF NEOPLASTIC PATIENTS (PTS), European journal of cancer, 31A, 1995, pp. 250-250
PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: BALLATORI E ROILA F DEANGELIS V TONATO M RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A COLELLA E CIRULLI S SABBATINI R FEDERICO M BARBIERI F SILINGARDI V ANNA S DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI Z MERIGGI F CORTESI E CALABRO F CARLO S LUPORINI G DANTONA A SANTORO A GIACOBONE A MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 13(9), 1995, pp. 2417-2426
CISPLATINUM BASED CHEMOTHERAPY - ROLE OF THE ANTISEROTONINERGIC ONDANSETRON IN PREVENTION OF EMESIS
Authors: LOCATELLI MC DANTONA A LUPORINI G
Citation: Mc. Locatelli et al., CISPLATINUM BASED CHEMOTHERAPY - ROLE OF THE ANTISEROTONINERGIC ONDANSETRON IN PREVENTION OF EMESIS, Journal of chemotherapy, 5(3), 1993, pp. 197-206
A PHASE-II STUDY OF COMBINATION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA WITH CISPLATIN AND CYCLOPHOSPHAMIDE PLUS REDUCED GLUTATHIONE AS POTENTIAL PROTECTIVE AGENT AGAINST CISPLATIN TOXICITY
Authors: LOCATELLI MC DANTONA A LABIANCA R VINCI M TEDESCHI M CARCIONE R CORBO A VENTURINO P LUPORINI G
Citation: Mc. Locatelli et al., A PHASE-II STUDY OF COMBINATION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA WITH CISPLATIN AND CYCLOPHOSPHAMIDE PLUS REDUCED GLUTATHIONE AS POTENTIAL PROTECTIVE AGENT AGAINST CISPLATIN TOXICITY, Tumori, 79(1), 1993, pp. 37-39
Risultati: 1-8 |